False Claims Act

Oberheiden P.C. Welcomes Former Federal Prosecutor Jennifer W. Corinis as New Litigation Counsel

Retrieved on: 
Friday, March 15, 2024
Bachelor of Arts, Knowledge, False Claims Act, Wellesley College, Fraud, Medicare, Government, Physician, Private investigator

, a premier Dallas-based litigation and compliance firm, proudly announces the addition of Jennifer W. Corinis to its team as Litigation Counsel.

Key Points: 
  • , a premier Dallas-based litigation and compliance firm, proudly announces the addition of Jennifer W. Corinis to its team as Litigation Counsel.
  • With a distinguished 25-year career that spans across various sectors of the legal system, Corinis brings a wealth of experience and expertise, particularly in federal civil and criminal litigation, as well as appeals.
  • Before joining Oberheiden P.C., Jennifer W. Corinis dedicated 14 years of her career to serving as a federal prosecutor, where she honed her skills in the courtroom, successfully trying a dozen federal cases on behalf of the United States and arguing numerous cases before the United States Court of Appeals.
  • Throughout her illustrious career, Corinis has achieved notable successes in defending federal agencies, companies, and individuals in high-stakes litigation.

Berger Montague Announces that its False Claims Act Whistleblower Case Against CVS Health Will Move Forward to Trial

Retrieved on: 
Thursday, April 4, 2024
Element, Employment, CVS Caremark, CVS, Rite Aid, Accusative case, Federation, District court, Pharmacy, False Claims Act, CVS Health, Fraud, Caremark, Multimedia, Medicare, Government, Court, PBM, Pharmaceutical industry

PHILADELPHIA, April 4, 2024 /PRNewswire/ -- Berger Montague PC is pleased to announce that its False Claims Act whistleblower case against CVS Caremark Corp. (including its pharmacy benefit manager subsidiary, CVS Caremark) for false drug pricing to Medicare will move forward to trial.

Key Points: 
  • PHILADELPHIA, April 4, 2024 /PRNewswire/ -- Berger Montague PC is pleased to announce that its False Claims Act whistleblower case against CVS Caremark Corp. (including its pharmacy benefit manager subsidiary, CVS Caremark) for false drug pricing to Medicare will move forward to trial.
  • The case is brought under the False Claims Act which allows private individuals to bring claims on behalf of the government to recover for fraud against the government.
  • In its summary judgment decision, the Court rejected the CVS Health defendants' attempt to have the claims dismissed without trial.
  • We are very pleased with the Court's ruling and look forward to presenting our case to a jury at trial," said Sorensen.

Lathrop GPM Lands Kathleen Fisher Enyeart as Counsel from Oracle

Retrieved on: 
Monday, March 25, 2024
Oracle Corporation, Cerner, Risk management, Growth, Human, Health, Private practice, Acquisition, AI, University, Crime, Woman, False Claims Act, Counsel, Oracle, Practice of law

KANSAS CITY, Mo., March 25, 2024 /PRNewswire-PRWeb/ -- Lathrop GPM LLP welcomes Kathleen Fisher Enyeart as Counsel to its distinguished Litigation practice group. She brings a formidable background that spans white-collar defense, litigation, healthcare and corporate compliance. Enyeart joined the firm on March 11, 2024, after several years as in-house counsel at Oracle and Cerner, respectively. Enyeart is located in the firm's Kansas City office and is focused on complex high-profile and bet-the-company litigation, as well as white-collar defense.

Key Points: 
  • KANSAS CITY, Mo., March 25, 2024 /PRNewswire-PRWeb/ -- Lathrop GPM LLP welcomes Kathleen Fisher Enyeart as Counsel to its distinguished Litigation practice group.
  • Enyeart joined the firm on March 11, 2024, after several years as in-house counsel at Oracle and Cerner, respectively.
  • Enyeart is located in the firm's Kansas City office and is focused on complex high-profile and bet-the-company litigation, as well as white-collar defense.
  • Prior to joining Lathrop GPM, Enyeart served as Vice President and Chief Health Compliance Officer at Oracle Corporation where she spearheaded a global team of more than 100 specialists.

Whistleblower Secures $70MM Settlement for Alleged Municipal Bond Fraud and Price-Fixing

Retrieved on: 
Thursday, March 21, 2024
Bank of America, Citigroup, McKool Smith, BMO, Bank, Morgan Stanley, False Claims Act, Lawyer, Fraud, JPMorgan Chase, Government, Barclays, Fifth Third Bank, Pharmaceutical industry

CHICAGO, March 21, 2024 /PRNewswire/ -- A $70 million settlement in a whistleblower lawsuit against eight of the nation's largest banks has been finalized and executed, making it the largest reported settlement ever under the Illinois False Claims Act.

Key Points: 
  • Edelweiss has brought similar lawsuits involving VRDOs on behalf of California, New York, and New Jersey, and those lawsuits are continuing.
  • Johan Rosenberg, the principal of Edelweiss with more than 30 years' experience advising municipalities and other clients on VRDOs and other types of municipal bonds, stated: "I am gratified by the settlement.
  • Under the False Claims Act in Illinois and numerous other states, whistleblowers can bring lawsuits on behalf of the government against those committing fraud against the government.
  • For its successful settlement in Illinois, Edelweiss received the maximum reward of 30% of the government's $48 million portion of the settlement.

McDermott Expands Litigation Practice, Eyes White-Collar and Government Investigation Growth Opportunities

Retrieved on: 
Thursday, March 14, 2024
McDermott Will & Emery, Government, Corruption, New York Law Journal, Sagar, Drug Enforcement Administration, Justice minister, Risk, Operation Car Wash, United States Attorney, Ethics, SDNY, History, Artificial intelligence, FCA, AI, Chambers and Partners, Security (finance), Foreign Corrupt Practices Act, DOJ, False Claims Act, Publication, Tourism, Fraud, FCPA, International law, Private investigator

WASHINGTON, March 14, 2024 /PRNewswire/ -- International law firm McDermott Will & Emery continues to add top talent to its Litigation Practice Group, announcing the following new hires who focus on Foreign Corrupt Practices Act (FCPA) and False Claims Act (FCA) matters and cybercrime:

Key Points: 
  • "These new hires reflect our commitment to looking around corners and providing new strategies clients can use to get ahead of potential enforcement matters."
  • He has consistently been recognized as a leading FCPA lawyer by publications including Chambers USA, Legal 500 and GIR Just Anti-Corruption.
  • Sagar brings almost a decade of experience as a federal prosecutor to advise companies and individuals facing government investigations and enforcement actions.
  • "We are delighted to welcome these partners to our team, extending our capabilities in FCPA and cyber issues, said Steven Scholes , global head of McDermott's Litigation Practice Group.

Opioid Qui Tam False Claims Act Case filed by Young Law Group, P.C. Part of $475 Million Department of Justice Settlement Against Endo Pharmaceuticals, Inc.

Retrieved on: 
Thursday, February 29, 2024
Human services, TRICARE, Oxymorphone, Courage, Physician, Marketing, FDA, Insufflation, YLG, Health, Pain, Complaint, Government, Perseverance, Medicare, Patient, OIG, False Claims Act, Prescription, Justice, Pharmaceutical industry

PLYMOUTH MEETING, Pa., Feb. 29, 2024 /PRNewswire/ -- Eric L. Young of Young Law Group , P.C.

Key Points: 
  • PLYMOUTH MEETING, Pa., Feb. 29, 2024 /PRNewswire/ -- Eric L. Young of Young Law Group , P.C.
  • Both the United States' and YLG's whistleblower complaints alleged that Endo fraudulently billed Medicare, Medicaid, TRICARE, and other federal healthcare programs for its role in fueling the ongoing opioid epidemic.
  • "Today's announcement serves as clear notice that the pharmaceutical industry's questionable, and often illegal, practices will not be tolerated," said Eric L. Young.
  • "This settlement is another important step in pushing back against Big Pharma's efforts to increase the use of deadly drugs by unsuspecting patients."

Healthcare False Claims Act Cases Account for Two-Thirds of Fraud Recoveries in Federal Fiscal Year 2023

Retrieved on: 
Wednesday, February 28, 2024
Human services, Quackery, Pharmacy, Court, Accusative case, Federation, Government, HHS, SCOTUS, FCA, Health care, Ground substance, DOJ, Bass, False Claims Act, FY, Publication, Supreme court, Controlled Substances Act, Pharmaceutical industry

NASHVILLE, Tenn., Feb. 28, 2024 /PRNewswire-PRWeb/ -- The U.S. Department of Justice (DOJ) reported civil fraud recoveries of nearly $2.7 billion in fiscal year (FY) 2023, with two-thirds of those recoveries in the healthcare industry, according to the 12th annual Healthcare Fraud & Abuse Review published today by law firm Bass, Berry & Sims.

Key Points: 
  • In its 12th annual Healthcare Fraud & Abuse Review, Bass, Berry & Sims provides analysis of healthcare fraud enforcement actions and False Claims Act developments probing SCOTUS cases, opioid enforcement and other areas.
  • -- Brian D. Roark
    Qui tam lawsuits filed by whistleblowers under the False Claims Act continue to be a driving force behind the government's civil healthcare fraud enforcement efforts.
  • Other hot-button issues likely will include the intersection of the False Claims Act with cybersecurity issues and the Controlled Substances Act, among others."
  • Providers should expect to see Controlled Substances Act compliance and the False Claims Act continue to intersect in enforcement actions.

False Claims Act Whistleblowers Recovered Over $2.3 Billion in FY 2023, Notes Kohn, Kohn & Colapinto

Retrieved on: 
Friday, February 23, 2024
Knowledge, False Claims Act, FCA, Kohn, Kohn & Colapinto, DOJ, Colapinto, Comment, Government, Multimedia, Pharmaceutical industry

WASHINGTON, Feb. 23, 2024 /PRNewswire/ -- In the 2023 Fiscal Year, the Department of Justice (DOJ) recovered over $2.3 billion in qui tam whistleblower cases, according to agency's False Claims Act (FCA) statistics released today .

Key Points: 
  • WASHINGTON, Feb. 23, 2024 /PRNewswire/ -- In the 2023 Fiscal Year, the Department of Justice (DOJ) recovered over $2.3 billion in qui tam whistleblower cases, according to agency's False Claims Act (FCA) statistics released today .
  • "The statistics once again show that whistleblowing works," says leading whistleblower attorney Stephen M. Kohn of Kohn, Kohn & Colapinto .
  • Under the False Claims Act , whistleblowers with knowledge of government contracting fraud may file qui tam lawsuits on behalf of the U.S. government.
  • Since the FCA's qui tam provisions were modernized in 1986, whistleblowers have recovered over $52.7 billion.

Beer Institute Lauds Introduction of Bill to Prevent Unfair Tariff Charges on Aluminum

Retrieved on: 
Monday, January 29, 2024
MWP, Legislation, Beer, Public policy, Policy, Aluminium, CO-04, Government, Beer Institute, False Claims Act, Consumer Brands Association, Accusative case, Midwestern United States, Pharmaceutical industry

Aluminum is the single largest input cost in brewing, and the lack of transparency in aluminum pricing hurts consumers.

Key Points: 
  • Aluminum is the single largest input cost in brewing, and the lack of transparency in aluminum pricing hurts consumers.
  • Imported primary aluminum and cansheet are critical to the U.S. beer industry as more than 74 percent of all beer produced in the United States is packaged in aluminum cans and bottles.
  • In 2020, brewers bought more than 41 billion aluminum cans and bottles, making aluminum the single most significant input cost in American beer manufacturing.
  • For additional updates from the Beer Institute, visit our website and follow us on X , LinkedIn , Facebook and Instagram .

Nixon Peabody promotes 12 attorneys in 2024 counsel class

Retrieved on: 
Wednesday, January 24, 2024
Senior counsel, Nixon Peabody, Housing, National Labor Relations Board, Redemption, Employment, Food, City, False Claims Act, Real estate, HUD, Labour, Disclosure, Recidivism, Patent, Restaurant, Dia, Intellectual property, Investment, CIPP, Rehabilitation, Private equity, Acquisition, NLRB, Hospital, Government, Partnership, Privacy, Private law, Leadership Council, Negotiation, Property management

BOSTON, Jan. 24, 2024 /PRNewswire-PRWeb/ -- Nixon Peabody LLP is proud to announce the law firm's 2024 counsel class, promoting 12 attorneys from a wide variety of practice areas and representing each of the firm's three legal departments. The counsel promotions are effective as of February 1, 2024.

Key Points: 
  • Nixon Peabody LLP is proud to announce the law firm's 2024 counsel class, promoting 12 attorneys from a wide variety of practice areas and representing each of the firm's three legal departments.
  • BOSTON, Jan. 24, 2024 /PRNewswire-PRWeb/ -- Nixon Peabody LLP is proud to announce the law firm's 2024 counsel class, promoting 12 attorneys from a wide variety of practice areas and representing each of the firm's three legal departments.
  • -Stacie B. Collier, Nixon Peabody Chief Talent Officer
    "Our new counsel class includes a broad range of backgrounds and perspectives, and the attorneys in this group have blazed their own trails within the firm," said Stacie B. Collier, Nixon Peabody Chief Talent Officer.
  • Illustrative of how integral the firm's counsel program has become to attorney development, 12 of the 14 attorneys in Nixon Peabody's 2024 partner class are being elevated from counsel.